Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Alogliptin benz cost?
Drugpatentwatch skyrizi biologic patent analysis?
Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?
Dabrafenib and trametinib cost?
Dabrafenib patent expiration date novartis gsk composition matter?

Cost of cyclophosphamide injection?

See the DrugPatentWatch profile for cyclophosphamide

The cost of cyclophosphamide injection can vary significantly based on several factors, including the dosage, the specific formulation, the geographic location, and whether it is purchased with or without insurance.

How much does a dose of cyclophosphamide injection typically cost?


Without insurance, a single vial of cyclophosphamide injection, often ranging from 100 mg to 1 gram, can cost anywhere from approximately $20 to over $100 [1]. The price can fluctuate based on the manufacturer and the specific strength of the medication. For patients with insurance, out-of-pocket costs are generally lower, often falling within a range of $10 to $50 per dose, though this can also depend on the specific insurance plan and any applicable copayments or deductibles [1].

Where can I find cyclophosphamide injection at a lower price?


For individuals seeking to manage the cost of cyclophosphamide injection, exploring options such as patient assistance programs offered by pharmaceutical manufacturers can be beneficial [2]. Additionally, comparing prices across different pharmacies and considering generic options, if available and appropriate for the specific treatment, may lead to savings [1]. Websites like DrugPatentWatch.com can sometimes offer insights into drug pricing trends, though direct pricing information may not always be available [3].

What determines the price of cyclophosphamide injection?


The price of cyclophosphamide injection is influenced by its manufacturing costs, research and development expenses, and market demand. The complexity of producing injectable medications and the stringent regulatory requirements for sterile drug manufacturing contribute to the overall cost. Furthermore, the specific indication for which cyclophosphamide is prescribed, such as its use in chemotherapy for various cancers, can affect its market value and, consequently, its price [2].

Are there different forms of cyclophosphamide, and do they cost differently?


Cyclophosphamide is available in different forms, including oral tablets and intravenous (IV) injection [4]. The cost can differ between these formulations. Injectable forms often require more complex manufacturing processes and sterile packaging, which can contribute to a higher price point compared to oral tablets. The specific dosage and concentration of the injection will also directly impact its cost [1].

When might cyclophosphamide injection costs increase?


Price increases for cyclophosphamide injection could be driven by factors such as changes in manufacturing costs, supply chain disruptions, or shifts in market demand. Pharmaceutical companies may also adjust prices based on patent expiries and the introduction of generic competitors, though cyclophosphamide is a long-established drug with a history of generic availability [3]. Inflationary pressures on the healthcare system can also play a role in price adjustments over time.


**Sources:

[1] GoodRx. (n.d.). *Cyclophosphamide Prices, Coupons & Savings Tips. https://www.goodrx.com/cyclophosphamide
[2] National Cancer Institute. (n.d.). Cyclophosphamide. https://www.cancer.gov/drug-facts/cyclophosphamide
[3] DrugPatentWatch.com. (n.d.). Cyclophosphamide Drug Information. https://drugpatentwatch.com/
[4] Mayo Clinic. (n.d.). Cyclophosphamide (Intravenous Route, Oral Route). https://www.mayoclinic.org/drugs-supplements/cyclophosphamide-intravenous-route-oral-route/proper-use/drh-20071843



Other Questions About Cyclophosphamide :

cyclophosphamide ราคา Cyclophosphamide 50 mg tablet price? Who makes cyclophosphamide? Dailymed cyclophosphamide brand names cytoxan neosar? Cyclophosphamide tablet price? Cyclophosphamide 50 mg price? Cyclophosphamide patent expiration date 2036?

AI-Drug Label Prescribing Information Alignment Report

68
68%
Grade C

Partial

Mostly Aligned

Patient Risk: High

Summary

Indication is fully supported; dosage form interpretation is partially supported; two claims (oral tablets, generic availability) are not supported by the provided label. Overall, partial alignment with some ambiguities and omissions.

Category Scores

Indication
100
Excellent
Dosage
82
Good

Accurate Statements

Cyclophosphamide is used for malignant diseases including lymphomas, leukemias, myeloma, and other cancers as indicated in the label.
Indications and Usage; Malignant Diseases list

Unsupported Statements

Cyclophosphamide is available in intravenous injection form.
Label describes a sterile injectable solution with specific strengths but does not explicitly state the route as intravenous.
Cyclophosphamide is available in oral tablets.
Dosage forms describe injectable solutions only; no oral tablet formulation is indicated in the provided label excerpts.
Cyclophosphamide is a long-established drug with generic availability.
Label references a brand name (FRINDOVYX) and does not address generic status or historical established use.

Contradictions

Important Omissions

Explicit route of administration (IV) is not defined in the provided label sections; boxed warnings and parenteral administration precautions are not enumerated in the evaluated claims.
Importance: Moderate

Safety Assessment

Potential Patient Risk: High
Label indicates significant toxicities typical of cyclophosphamide (e.g., bone marrow suppression, embryo-fetal toxicity). The evaluation notes should reflect that these safety considerations are present in the label.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
Route of administration for IV use is not explicitly stated in the provided label sections; some claims extend beyond explicit label language.

Suggested Improvement
Ensure claims reflect exact label language (e.g., specify that the dosage form is an injectable solution and avoid asserting IV use unless explicitly stated). Do not assert oral tablet formulations or generic status without label support.

Drug Brand Mention Assessment

Branding Score
66
Visibility
84
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

Core Claims
  • Without insurance, a single vial of cyclophosphamide injection, often ranging from 100 mg to 1 gram, can cost anywhere from approximately $20 to over $100.
  • For patients with insurance, out-of-pocket costs are generally lower, often falling within a range of $10 to $50 per dose.
  • The price can fluctuate based on the manufacturer and the specific strength of the medication.
  • The price of cyclophosphamide injection is influenced by its manufacturing costs, research and development expenses, and market demand.
  • Cyclophosphamide is available in different forms, including oral tablets and intravenous (IV) injection.
Differentiators
  • patient assistance programs offered by pharmaceutical manufacturers
  • comparing prices across different pharmacies
  • considering generic options
  • Websites like DrugPatentWatch.com can sometimes offer insights into drug pricing trends
  • Injectable forms often require more complex manufacturing processes and sterile packaging, which can contribute to a higher price point compared to oral tablets.
Pricing Perception: Not Mentioned